MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 629-633

  Hoenig, Michel R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Sagittal abdominal diameter; Visceral fat area; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PREDICTION; QUICK INDEX; SAGITTAL ABDOMINAL DIAMETER; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ABDOMEN; CHI SQUARE DISTRIBUTION; NONPARAMETRIC TEST; PATHOLOGY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICAL MODEL;

ABDOMEN; ADIPOSITY; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE;

EID: 79952053418     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/vhrm.s10787     Document Type: Article

References (22)

1. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol. 2006;47:1093-1100.
2. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
3. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med. 2006;38:64-80.
4. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-2094.
5. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
6. Vlek AL, van der Graaf Y, Spiering W, Visseren FL. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients. J Hum Hypertens. 2008;22:358-365.
7. Vlek AL, van der Graaf Y, Sluman MA, Moll FL, Visseren FL, Group SS. Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease. J Vasc Surg. 2009;50:61-69.
8. Wassink AM, van der Graaf Y, Soedamah-Muthu SS, Spiering W, Visseren FLJ; Smart Study Group. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diab Vasc Dis Res. 2008;5:114-122.
9. Brevetti G, Laurenzano E, Giugliano G, Lanero S, Brevetti L, Luciano R, Chiariello M, 2010, Nutrition, Metabolism and Cardiovascular Diseases, 20(9), 676-682
10. Valsamakis G, Chetty R, Anwar A, Banerjee AK, Barnett A, Kumar S. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med. 2004;21:1339-1345.
11. Riserus U, Arnlov J, Brismar K, Zethelius B, Berglund L, Vessby B. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diab Care. 2004;27:2041-2046.
12. Petersson H, Daryani A, Riserus U. Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study. Cardiovasc Diabetol. 2007;6:10.
13. Ohrvall M, Berglund L, Vessby B. Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes Relat Metab Disord. 2000;24:497-501.
14. Valsamakis G, Jones A, Chetty R, et al. MRI total sagittal abdominal diameter as a predictor of metabolic syndrome compared to visceral fat at L4-L5 level. Curr Med Res Opin. 2008;24:1853-1860.
15. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39-48.
16. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diab Care. 1999;22:1808-1812.
17. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
18. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15-E26.
19. Sarafidis PA, Lasaridis AN, Nilsson PM, et al. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens. 2007;21:709-716.
20. Chowdhury B, Sjöström L, Alpsten M, Kostanty J, Kvist H, Löfgren R. A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord. 1994;18: 219-234.
21. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity. Circulation. 2009;120:1640-1645.
22. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am. 2008;37:581-601, 7-8.